BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31500062)

  • 21. pH-responsive charge-reversal polymer-functionalized boron nitride nanospheres for intracellular doxorubicin delivery.
    Feng S; Zhang H; Zhi C; Gao XD; Nakanishi H
    Int J Nanomedicine; 2018; 13():641-652. PubMed ID: 29440891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
    Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
    Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.
    Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P
    Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
    Cao W; Zhou J; Mann A; Wang Y; Zhu L
    Biomacromolecules; 2011 Jul; 12(7):2697-707. PubMed ID: 21619062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folic acid conjugated poly (Amidoamine) dendrimer grafted magnetic chitosan as a smart drug delivery platform for doxorubicin: In-vitro drug release and cytotoxicity studies.
    Soltany P; Miralinaghi M; Pajoum Shariati F
    Int J Biol Macromol; 2024 Feb; 257(Pt 1):127564. PubMed ID: 37865361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual targeted delivery of doxorubicin to cancer cells using folate-conjugated magnetic multi-walled carbon nanotubes.
    Lu YJ; Wei KC; Ma CC; Yang SY; Chen JP
    Colloids Surf B Biointerfaces; 2012 Jan; 89():1-9. PubMed ID: 21982868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GSH and enzyme responsive nanospheres based on self-assembly of green tea polyphenols and BSA used for target cancer chemotherapy.
    Zhang J; Ren X; Tian X; Zhang P; Chen Z; Hu X; Mei X
    Colloids Surf B Biointerfaces; 2019 Jan; 173():654-661. PubMed ID: 30368213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia-responsive folic acid conjugated glycol chitosan nanoparticle for enhanced tumor targeting treatment.
    Jang EH; Shim MK; Kim GL; Kim S; Kang H; Kim JH
    Int J Pharm; 2020 Apr; 580():119237. PubMed ID: 32201251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery.
    Huang H; Yang DP; Liu M; Wang X; Zhang Z; Zhou G; Liu W; Cao Y; Zhang WJ; Wang X
    Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development, characterization and cancer targeting potential of surface engineered carbon nanotubes.
    Mehra NK; Jain NK
    J Drug Target; 2013 Sep; 21(8):745-58. PubMed ID: 23822734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
    Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
    Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of novel biofunctionalized chitosan decorated nanocochleates as a cancer targeted drug delivery platform.
    Bothiraja C; Rajput N; Poudel I; Rajalakshmi S; Panda B; Pawar A
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):447-461. PubMed ID: 29368543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy.
    Ma N; Liu J; He W; Li Z; Luan Y; Song Y; Garg S
    J Colloid Interface Sci; 2017 Mar; 490():598-607. PubMed ID: 27923144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-assembly of morphology-tunable architectures from tetraarylmethane derivatives for targeted drug delivery.
    Huang X; Jeong YI; Moon BK; Zhang L; Kang DH; Kim I
    Langmuir; 2013 Mar; 29(10):3223-33. PubMed ID: 23425332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
    Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
    Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy.
    Bi D; Zhao L; Yu R; Li H; Guo Y; Wang X; Han M
    Drug Deliv; 2018 Nov; 25(1):564-575. PubMed ID: 29457518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
    Huang Y; Mao K; Zhang B; Zhao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a multifunctional system based on CoFe
    Arkaban H; Khajeh Ebrahimi A; Yarahmadi A; Zarrintaj P; Barani M
    Nanotechnology; 2021 May; 32(30):. PubMed ID: 33857938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
    Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
    Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.